BayBG joins HTGF and Bayern Kapital in €1m GME series-A

Prior to the series-A round, HTGF and Bayern Kapital invested €750,000 in a seed round for the business in late 2011.

GME received CE approval for its first product, a CO2 laser to treat wrinkles, at the end of 2012. The company now plans to launch one or two new products per year and will use the current funding to market its products worldwide.

Company
Nuremberg-based GME was founded in June 2011. The company invents and markets medical devices based on laser and light systems for treating skin diseases and aesthetic applications.

People
Marcus Gulder is head of BayBG's venture capital division, while Otto Hopfner is investment manager at the firm. 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• Healthcare
• Bayerische Beteiligungsgesellschaft mbH (BayBG)
• High-Tech Gründerfonds
• Germany